Make an Appointment

Ask a Question
Refer a Patient

1.877.CALL NJH
(877.225.5654)

Insomnia Therapy

Trial Location:
Main Campus, Denver, CO
Principal Investigator:

Jack Edinger, PhD

Trial Sponsor(s):

National Institutes of Health

Trial Objective:

The purpose of this study is to learn more about the effectiveness of first- and second-stage therapies for insomnia among individuals who have insomnia alone or in combination with a coexisting psychiatric disorder.

If you decide to enroll this study your participation will last for 16 months, the following things will happen:

  • Initial screening evaluation visit.
  • Maintain a sleep diary.
  • For those who qualify, 6 to 12 weeks of insomnia treatment. 
  • Undergo sleep study.
  • 4 follow-up visits.

Download the flyer for information on this clinical trial.

Compensation:

Provided

Who Can Participate:

Participants must be 21 years of age and older with chronic insomnia which is difficulty falling asleep or staying asleep despite adequate opportunity for sleep.

Enrollment:

Active Clinical Trials Currently Recruiting

How to Participate:

For more information, please contact Ann Depew, the study coordinator by email at DepewA@NJHealth.org and by phone at 303.398.1149.

Related Conditions




Request More Information
Bookmark and Share